Bovine Coccidiosis: Etiology, Clinical Pathology, and Therapeutic Management in Cattle

Introduction

Bovine coccidiosis is an economically important enteric disease of cattle worldwide, caused by apicomplexan parasites of the genus Eimeria (family Eimeriidae). The disease primarily affects young calves and weanlings, manifesting as diarrhea, dehydration, weight loss, and occasionally death [1, 2]. Eimeria spp. are host-specific obligate intracellular parasites that undergo both asexual and sexual reproduction within the intestinal epithelium, leading to mucosal damage and secondary bacterial dysbiosis [3, 4]. This article provides a detailed reference on the etiology, clinical pathology, diagnosis, and therapeutic management of bovine coccidiosis, integrating recent molecular, epidemiological, and experimental findings.

Etiology and Parasite Biology

Causal Agents

Bovine coccidiosis is caused by several Eimeria species. A global systematic review and meta-analysis identified Eimeria bovis, Eimeria zuernii, and Eimeria alabamensis as the most prevalent pathogenic species in cattle [1]. Eimeria bovis and E. zuernii are considered the primary causative agents of clinical disease, although mixed infections with less pathogenic species such as Eimeria auburnensis, Eimeria ellipsoidalis, and Eimeria canadensis are common [5, 2]. Molecular characterization using 18S rRNA gene fragments has confirmed species diversity and genetic variation among bovine Eimeria populations [6, 3].

Life Cycle

The life cycle of Eimeria spp. is monoxenous, consisting of an exogenous sporulation phase and an endogenous phase within the bovine host [7, 8].

1. Exogenous sporulation: Unsporulated oocysts are excreted in feces. Under appropriate conditions of temperature, humidity, and oxygen, oocysts sporulate to become infective within 2 to 7 days [1, 9].
2. Ingestion and excystation: Cattle ingest sporulated oocysts from contaminated feed, water, or pasture. Sporozoites excyst in the small intestine and invade epithelial cells [7].
3. Asexual reproduction (schizogony): Sporozoites develop into schizonts, which undergo multiple rounds of merogony. Eimeria bovis is characterized by macromeront formation (large schizonts containing thousands of merozoites), which induces bystander cell accumulation and tunneling nanotube formation in host tissues [7].
4. Sexual reproduction (gametogony): Merozoites enter host cells and differentiate into macrogametes and microgametes. Fertilization forms a zygote that develops into an unsporulated oocyst, which is shed in feces [8].

The prepatent period for E. bovis is approximately 21 days; for E. zuernii, it is 16 to 18 days [10, 4].

Pathogenic Mechanisms

Pathogenicity arises from the lytic destruction of intestinal epithelial cells during schizogony. Macromeronts of E. bovis can occupy entire villi, leading to extensive tissue necrosis, hemorrhage, and inflammation [7, 3]. Secondary bacterial overgrowth exacerbates the condition. The intracellular parasites subvert host cell signaling to promote nutrient uptake and suppress apoptosis [8]. Severe infections can lead to hypoproteinemia, electrolyte imbalances, and secondary infections [2].

Epidemiology and Risk Factors

Prevalence and Geographic Distribution

Bovine coccidiosis is ubiquitous in cattle-rearing regions. A systematic review and meta-analysis covering global data from 2000 to 2025 estimated an overall prevalence of Eimeria spp. in cattle at 47.2% (95% CI: 41.8 to 52.6) [1]. Regional differences exist; in Iran, the pooled prevalence was 38.4% [9], while in East Java, Indonesia, it reached 64.3% [4]. In Central Argentina, a retrospective study found that 32.1% of necropsied calves had coccidiosis-related lesions [2].

Risk Factors

Several risk factors predispose cattle, particularly calves, to clinical coccidiosis:

• Age: Calves aged 3 weeks to 6 months are most susceptible. Weaning stress increases vulnerability [5, 2].
• Housing and hygiene: Overcrowding, poor sanitation, and contaminated bedding facilitate oocyst accumulation [1, 9].
• Season: Outbreaks often peak during wet seasons when oocyst sporulation is optimal [10].
• Co-infections: Concomitant infection with Cryptosporidium spp. or other enteric pathogens worsens diarrhea severity [10].
• Nutritional status: Malnutrition and sudden dietary changes can impair immune defenses [5, 3].

Clinical Pathology

Clinical Signs

Clinical presentation ranges from subclinical infection to severe enteritis. Characteristic signs include:

• Diarrhea: Watery to hemorrhagic feces, often with mucus and fibrinous casts [2, 4].
• Tenesmus and dyschezia: Frequent straining and passage of blood-stained mucus.
• Dehydration and weakness: Loss of fluid and electrolytes leads to sunken eyes and recumbency.
• Anorexia and weight loss: Reduced feed intake and malabsorption contribute to poor growth [1, 5].
• Fever: Moderate pyrexia may be present, especially in acute cases [2].

In severe infections, calves may die within 48 hours of onset, particularly with E. zuernii infections that cause extensive hemorrhagic typhlocolitis [10, 3].

Gross Pathology

Postmortem examination reveals:

• Thickened, edematous intestinal mucosa with petechial hemorrhages, especially in the cecum, colon, and distal ileum [2, 4].
• Fibrinonecrotic enteritis: Yellowish pseudomembranes adherent to the mucosa.
• Hemorrhagic content: Blood-tinged fluid in the lumen.
• Mucosal smears may contain visible schizonts and macrogametes [3, 8].

Histopathology

Microscopic changes include:

• Epithelial cell destruction with loss of villous architecture.
• Intracellular schizonts and gametocytes within enterocytes and crypt cells.
• Mononuclear and neutrophilic infiltration in the lamina propria.
• Macromeronts of E. bovis are visible in the submucosa, forming large clusters that compress adjacent tissues [7].

Hematological and Biochemical Alterations

Hematological changes reflect acute inflammation and blood loss:

• Anemia: Normocytic, normochromic anemia due to intestinal hemorrhage.
• Leukocytosis or leukopenia: Depending on the stage and severity.
• Hypoproteinemia: Decreased albumin and globulin due to protein-losing enteropathy [2, 3].
• Electrolyte imbalances: Hyponatremia, hypochloremia, and metabolic acidosis.

Diagnosis

Clinical Diagnosis

A presumptive diagnosis is based on age, clinical signs, and history of exposure to contaminated environments. However, definitive diagnosis requires laboratory confirmation [10, 4].

Fecal Examination

Standard diagnostic method is fecal flotation (e.g., Sheather's sugar solution or saturated NaCl) to detect oocysts. Quantitative techniques (McMaster counting chamber) provide oocysts per gram (OPG) of feces. Clinical disease is typically associated with OPG counts exceeding 5,000 to 10,000, although counts vary [1, 5].

Speciation

Species identification relies on oocyst morphology (size, shape, color, and presence of micropyle or polar cap) or molecular methods [6, 3]. Microscopic features are detailed in Table 1.

Table 1. Morphological features of selected bovine Eimeria species.

Species identification is important for epidemiologic studies and to differentiate pathogenic from non-pathogenic species [1, 9].

Molecular Diagnostics

Polymerase chain reaction (PCR) targeting the 18S rRNA gene is widely used for sensitive detection and species differentiation. Comparison of 18S rRNA gene fragments and reference databases (e.g., GenBank) allows accurate phylogenetic placement [6, 11]. Quantitative PCR (qPCR) can estimate parasitic load. Molecular methods are especially useful when oocyst morphology is ambiguous [5, 3].

Differential Diagnosis

Coccidiosis must be differentiated from other causes of diarrhea in calves, including:

• Bacterial enteritis (e.g., Escherichia coli, Salmonella spp., Clostridium perfringens)
• Viral enteritis (e.g., rotavirus, coronavirus)
• Cryptosporidiosis
• Nutritional diarrhea
• Parasitic gastroenteritis caused by other nematodes [10, 2]

Co-infections are common; a study in Japan confirmed that Cryptosporidium and Eimeria frequently co-occur in diarrheic calves [10].

Therapeutic Management

Anticoccidial Drugs

The mainstay of therapy is the use of anticoccidial agents. Commonly used drugs include ionophores (e.g., monensin, lasalocid) and triazines (e.g., toltrazuril, diclazuril). Toltrazuril is effective against both asexual and sexual stages and is approved for oral administration in many countries [8, 4].

Phytotherapeutic Approaches

Research has explored plant-based anticoccidials. Papaya (Carica papaya) latex and pure papain have been shown to inhibit E. bovis oocyst sporulation in vitro [11]. Extracts of Syzygium cumini and Trachyspermum ammi exhibit anticoccidial activity against E. zuernii through combined in vitro, in vivo, and in silico approaches, with active compounds binding to parasite enzymes [8]. These phytotherapeutics may offer alternatives to synthetic drugs, pending further validation.

Supportive Care

Supportive therapy is critical, especially in acute cases:

• Fluid therapy: Intravenous or oral electrolyte solutions to correct dehydration and acidosis.
• Nutritional support: Easily digestible, high-energy feed.
• Probiotics and prebiotics to restore gut flora.
• Anti-inflammatory drugs may be used to reduce mucosal inflammation.
• Antimicrobials are indicated if secondary bacterial infection is suspected [2, 3].

Control and Prevention

Preventive strategies focus on:

• Hygiene: Regular removal of manure, disinfection of pens, and provision of clean, dry bedding.
• Management: Avoid overcrowding; separate age groups to reduce oocyst exposure [1, 5].
• Pasture management: Rotational grazing to reduce contamination.
• Chemoprophylaxis: Ionophores or toltrazuril can be administered during high-risk periods (e.g., weaning, housing) [8, 4].
• Vaccination: No commercial bovine coccidiosis vaccine is widely available; research is ongoing.

Diagnostic and Management Workflow

The following diagram outlines a clinical decision algorithm for bovine coccidiosis.

flowchart TD
    A[Calves 3 weeks to 6 months presenting with diarrhea] --> B{Clinical signs?}
    B -->|Watery/hemorrhagic feces, tenesmus, dehydration| C[Collect fecal sample]
    C --> D[Fecal flotation and OPG count]
    D --> E{OPG > 5,000?}
    E -->|Yes| F[Speciation via morphology or PCR]
    F --> G[Confirm pathogenic species?]
    G -->|Yes| H[Initiate anticoccidial therapy]
    H --> I["Supportive care: fluids, nutrition"]
    I --> J["Monitor response; re-check OPG"]
    J --> K[Recovery or referral]
    E -->|No| L[Consider other etiologies]
    L --> M["Differential diagnosis: bacterial, viral, Cryptosporidium"]
    M --> N[Perform additional tests]
    N --> O[Treat according to etiology]

Future Directions

Advances in molecular diagnostics, including high-throughput amplicon sequencing of 18S rRNA genes, enable comprehensive Eimeria community profiling [6, 3]. Understanding pathogenicity mechanisms, such as the role of macromeront-induced tunneling nanotubes, may inform novel therapeutic interventions [7]. Meta-analyses of risk factors and species distribution provide evidence-based guidelines for targeted control [1, 9]. The potential of plant-derived anticoccidials merits continued investigation in clinical trials [11, 8].

References

[1] Shamsi L, Pouryousef A, Mohammadi MR, et al. Eimeria spp. in Cattle: A Global Systematic Review and Meta-Analysis. Vet Med Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/42113544/

[2] Vilatuña EJ, Cantón G, Ovelar MF, et al. Bovine coccidiosis: Retrospective study in Central Argentina. Vet Parasitol Reg Stud Reports. 2026. https://pubmed.ncbi.nlm.nih.gov/41651633/

[3] Lang J, Qin H, Zhao J, et al. Morphological and molecular identification of Eimeria spp. (Apicomplexa: Eimeriidae) in dairy cattle, Bos taurus from intensive dairy cattle farms in some areas of China. Vet Parasitol. 2025. https://pubmed.ncbi.nlm.nih.gov/41045725/

[4] Hastutiek P, Suwanti LT, Suprihati E, et al. Bovine coccidiosis and molecular characterization of pathogenic Eimeria species in dairy cattle on Grati-Pasuruan, East Java, Indonesia. Open Vet J. 2025. https://pubmed.ncbi.nlm.nih.gov/40453855/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[5] Arsenopoulos KV, Chrysanthopoulos S, Papadopoulos E. Molecular Investigation of Eimeria spp. Infection in Weaned Dairy Calves in Thessaly, Greece, and Associated Risk Factors. Int J Mol Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/41898762/

[6] Lee S, Youn SY, Seo MG, et al. Comparison of 18S rRNA gene fragments and reference databases for assessing bovine Eimeria diversity using the Illumina platform. Vet Parasitol. 2026. https://pubmed.ncbi.nlm.nih.gov/42105682/

[7] Fischer J, Sous L, Velásquez ZD, et al. Intracellular Eimeria bovis macromeront formation induces bystander cell accumulation and TNT formation. Front Cell Infect Microbiol. 2025. https://pubmed.ncbi.nlm.nih.gov/41112577/

[8] Sarfaraz MZ, Abbas S, Zaman MA, et al. Phytochemical profiling and anticoccidial activity of Syzygium cumini and Trachyspermum ammi extracts against Eimeria zuernii: Integrated in vitro, in vivo, and in silico approaches. Vet Parasitol. 2025. https://pubmed.ncbi.nlm.nih.gov/40945468/

[9] Disfani RA, Shadfar F, Mohammadi MR, et al. Systematic Review and Meta-Analysis of the Prevalence, Species Distribution and Risk Factors of Eimeria spp. in Iranian Livestock. Vet Med Sci. 2025. https://pubmed.ncbi.nlm.nih.gov/40509950/

[10] Kabir MHB, Murakoshi F, Fukuda Y, et al. Identification of Cryptosporidium and Eimeria associated with diarrhea in calves in Japan (2020-2022). Parasitol Res. 2026. https://pubmed.ncbi.nlm.nih.gov/41667631/

[11] de Siqueira LN, de Souza DCT, Mamani RCC, et al. In Vitro Action of Papaya (Carica Papaya) Latex and Pure Papain Against Eimeria Bovis Oocysts. Acta Parasitol. 2025. https://pubmed.ncbi.nlm.nih.gov/41100022/